2017. ESMO Immuno-Oncology Congress – Health-Related Quality of Life (HRQoL) in Patients (Pts) With Merkel Cell Carcinoma (MCC) Receiving Avelumab (81P)

Bharmal M, Williams P, Hennessy M, Schlichting M,  Hunger M, Marrel A, Kaufman H. Health-Related Quality of Life (HRQoL) in Patients (Pts) With Merkel Cell Carcinoma (MCC) Receiving Avelumab (81P). Annals of Oncology (2017) 28 (suppl_11): xi6-xi29. 10.1093/annonc/mdx711. Presented at: ESMO Immuno-Oncology Congress 2017; December 8, 2017; Geneva, Switzerland.